Watch SYRA. Know when insiders buy.
One email the day a filing lands. Free.
SYRA
Syra Health Corp
0.84
−0.04 −4.33%
USD · close Sep 28
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
47
WATCH · shorts 47
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $11.6MP/E —DIV YIELD —FCF YIELD —REV TTM $8.1M +0.3%NET INCOME $131KNET CASH —52W 0.06 – 1.05SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $2.4M | +23.0% | 44.5% | $252K | $250K | — | 0.02 | −$719K | — | — | Aug 11 |
| Q1 2026 · Mar 31 | $2.3M | +22.4% | 42.7% | $191K | $241K | — | 0.02 | $1.4M | — | — | Aug 11 |
| Q4 2025 · Dec 31derived | $1.7M | −13.6% | 34.1% | −$136K | −$135K | — | -0.02 | −$289K | — | — | Mar 12 |
| Q3 2025 · Sep 30 | $1.7M | −25.1% | 32.9% | −$232K | −$226K | — | -0.02 | −$244K | — | — | Nov 12 |
| Q2 2025 · Jun 30 | $1.9M | −1.2% | 38.7% | −$63K | −$64K | — | -0.01 | −$72K | — | — | Aug 11 |
| Q1 2025 · Mar 31 | $1.9M | +6.0% | 31.7% | −$473K | −$472K | — | -0.04 | $158K | — | — | Aug 11 |
| Q4 2024 · Dec 31derived | $2M | +13.6% | 16.7% | −$502K | −$504K | — | -0.02 | −$215K | $0 | −$215K | Mar 12 |
| Q3 2024 · Sep 30 | $2.3M | +42.5% | 29.7% | −$429K | −$418K | — | -0.06 | −$413K | $0 | −$413K | Nov 12 |
| Q2 2024 · Jun 30 | $2M | — | 17.8% | −$1.4M | −$1.4M | — | -0.21 | −$1.5M | $5K | −$1.5M | Nov 12 |
| Q1 2024 · Mar 31 | $1.8M | — | 17.1% | −$1.4M | −$1.4M | — | -0.22 | −$801K | $6K | −$806K | Nov 12 |
| Q4 2023 · Dec 31derived | $1.8M | — | 33.0% | −$986K | −$995K | — | -0.16 | −$1.8M | $0 | −$1.8M | Mar 11 |
| Q3 2023 · Sep 30 | $1.6M | — | 35.1% | −$343K | −$354K | — | -0.08 | −$369K | $0 | −$369K | Oct 29 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $7.2M | 34.4% | −$904K | −$896K | -12.4% | -0.08 | −$448K | $107 | −$448K | — | — |
| FY2024 · to Dec 31 | $8M | 20.7% | −$3.8M | −$3.8M | -47.1% | -0.50 | −$2.9M | $11K | −$2.9M | — | — |
| FY2023 · to Dec 31 | $5.5M | 25.6% | −$2.9M | −$2.9M | -53.3% | -0.60 | −$2.8M | $15K | −$2.8M | — | — |
| FY2022 · to Dec 31 | $5.6M | 18.9% | −$2.1M | −$2.1M | -37.7% | -0.70 | −$2.2M | $121K | −$2.4M | — | — |
Every number comes from Syra Health Corp's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.